http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112336720-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112336720-B
titleOfInvention Aspirin and ticlopidine compound preparation and preparation method thereof
abstract The invention provides an aspirin and ticlopidine compound preparation and a preparation method thereof. The aspirin and ticlopidine compound preparation comprises: the enteric-coated tablet comprises an enteric-coated tablet core and a gastric-coated shell, wherein the active ingredient of the tablet core is aspirin, and the gastric-coated shell is coated outside the enteric-coated tablet core to form a core-coated tablet; the shell layer with gastric solubility contains microparticles; the microparticles comprise polyethylene glycol positioned on the surface layer and contents positioned in the inner part; the content contains ticlopidine. In the aspirin and ticlopidine compound preparation, the ticlopidine and the aspirin are not in direct contact with each other, so that the mutual interference of two medicinal components is avoided; but also improves stability during storage.
priorityDate 2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4080447-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413581692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86740929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227

Total number of triples: 44.